Prostate cancer uses metabolic switch to thrive after hormone therapy
AstraZeneca hails US trials as EU rows with UK over supplies
22 March 2021Ask the Pediatrician: Are infrared thermometers safe to use on children?
22 March 2021Prostate cancer uses metabolic switch to thrive after hormone therapy
Studying the cellular metabolism of prostate cancer, a team of Duke Health-led researchers identified a key reason hormone therapies eventually fail, while also laying out a way to bypass the problem using an entirely new therapeutic approach.
